Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Clever Leaves Holdings Inc. (CLVR) vs InterCure Ltd. (INCR)

Clever Leaves Holdings Inc. and InterCure Ltd. are both Drug Manufacturers Specialty & Generic companies. Clever Leaves Holdings Inc. is the larger, with a market value of $96.5M against $62.3M — 1.5× the size. Clever Leaves Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 9.8×. InterCure Ltd. grew revenue faster over the last twelve months: 16.2% against 6.14%. InterCure Ltd. has the higher net margin (4.88% vs −102.8%) and the higher return on invested capital (0.00% vs −52.6%). Across the 16 metrics below, InterCure Ltd. leads on 9 and Clever Leaves Holdings Inc. on 7.

Valuation

Metric CLVR INCR Drug Manufacturers Specialty & Generic median
P/E n/m 9.84 20.14
P/S n/m 1.98 2.25
P/B n/m 1.96 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 0.45 23.47 12.29
EV/Sales (0.33) 2.12 2.56
Earnings yield 0.00% 10.16% (2.99%)
Free cash flow yield 0.00% (0.34%) 0.00%

Profitability

Metric CLVR INCR Drug Manufacturers Specialty & Generic median
Gross margin 37.64% 32.74% 53.94%
Operating margin (89.53%) 0.00% 0.00%
Net margin (102.77%) 4.88% 0.00%
Free cash flow margin (49.82%) 0.00% 0.00%
Return on equity (55.39%) 0.00% (0.40%)
Return on assets (42.95%) 0.00% (3.32%)
Return on invested capital (52.59%) 0.00% 0.00%

Growth

Metric CLVR INCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 6.14% 16.15% 10.01%
EPS growth (last fiscal year) 77.89% 52.50% —
Revenue growth, 5-year CAGR — 31.11% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLVR INCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 0.27 0.05
Current ratio 2.40 1.85 2.31
Net debt to EBITDA 0.45 (4.07) 0.85

Dividend

Metric CLVR INCR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CLVR INCR Drug Manufacturers Specialty & Generic median
Market cap 96.49m 62.33m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack